<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-07T09:06:33Z</responseDate>
  <request identifier="oai:figshare.com:article/34039839" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34039839</identifier>
        <datestamp>2026-10-01T05:43:29Z</datestamp>
        <setSpec>category_393</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Supplementary file 1_LDAR shows more consistent prognostic performance than other albumin-derived indices for 28-day ICU mortality in critically ill patients with urosepsis: evidence from a dual-cohort retrospective study.docx</dc:title>
          <dc:creator>Yi Mu (519696)</dc:creator>
          <dc:creator>Hao Tang (44155)</dc:creator>
          <dc:creator>Yan Zeng (120271)</dc:creator>
          <dc:creator>Qian Wang (32718)</dc:creator>
          <dc:creator>Tao Huang (110613)</dc:creator>
          <dc:creator>Wei Li (7081)</dc:creator>
          <dc:creator>Xiangbo Wu (9090356)</dc:creator>
          <dc:creator>Shengming Pi (25153113)</dc:creator>
          <dc:subject>Foetal Development and Medicine</dc:subject>
          <dc:subject>albumin-derived indices</dc:subject>
          <dc:subject>critical care</dc:subject>
          <dc:subject>deep learning</dc:subject>
          <dc:subject>nutritional intervention</dc:subject>
          <dc:subject>risk stratification</dc:subject>
          <dc:description>Background&lt;p&gt;Urosepsis remains a leading cause of ICU mortality. Albumin-derived composite indices, which integrate nutritional, inflammatory, and metabolic parameters, hold prognostic promise; however, their comparative performance has not been directly assessed.&lt;/p&gt;Methods&lt;p&gt;We conducted a dual-cohort retrospective study using MIMIC-IV (n = 3,060) for derivation and the Affiliated Hospital of Guizhou Medical University (n = 353) for validation. The primary outcome was 28-day ICU mortality in a competing-risks framework with discharge alive as competing event. Six indices—lactate dehydrogenase-to-albumin ratio (LDAR), anion gap-to-albumin ratio (AGAR), glucose-to-albumin ratio (GAR), red cell distribution width-to-albumin ratio (RAR), total bilirubin-to-albumin ratio (TAR), and urea nitrogen-to-albumin ratio (UAR)—were compared via cause-specific Cox and Fine-Gray subdistribution hazard models, cumulative incidence functions, restricted cubic splines (RCS), Kaplan-Meier curves, and ROC/Youden/cNRI analyses. LASSO-selected features trained a multilayer perceptron (MLP), benchmarked against six severity scores; a parsimonious external model (events per variable ≥ 10) was also examined.&lt;/p&gt;Results&lt;p&gt;In the derivation cohort, logLDAR, RAR, TAR, AGAR, and UAR were independently associated with 28-day ICU mortality in fully adjusted models (HRs = 1.292, 1.147, 1.136, 1.074, and 1.013, respectively; all P &lt; 0.01), whereas logGAR was not. Fine-Gray models corroborated these findings (logLDAR sHR = 1.351, 95% CI: 1.238–1.473). RCS revealed a non-linear logLDAR–mortality relationship (P non-linear = 0.040), with risk accelerating beyond logLDAR &gt; 7. logLDAR yielded the highest AUC (0.638, 95% CI: 0.609–0.667) and cNRI (0.119). External validation confirmed the independent prognostic value of logLDAR (HR = 1.524, 95% CI: 1.225–1.895; Fine-Gray sHR = 1.545, 95% CI: 1.295–1.844), with an external AUC of 0.735 (95% CI: 0.648–0.808), although between-cohort differences in case definitions may partly contribute. The MLP with eight LASSO-selected features achieved an external AUC of 0.762 (95% CI: 0.687–0.840), comparable to SOFA plus logLDAR (AUC = 0.782; DeLong P = 0.512). SHAP analysis ranked logLDAR among the top predictors.&lt;/p&gt;Conclusion&lt;p&gt;Among the six albumin-derived indices, logLDAR demonstrated the most consistent and generalizable prognostic performance for 28-day ICU mortality in urosepsis, reflecting both tissue hypoxia and nutritional-inflammatory depletion, and remained robust under competing-risk adjustment. logLDAR may serve as a simple bedside biomarker for early risk stratification; however, prospective studies are warranted to determine whether interventions targeting its underlying pathways can improve outcomes.&lt;/p&gt;</dc:description>
          <dc:date>2026-10-01T05:43:29Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fmed.2026.1915095.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Supplementary_file_1_LDAR_shows_more_consistent_prognostic_performance_than_other_albumin-derived_indices_for_28-day_ICU_mortality_in_critically_ill_patients_with_urosepsis_evidence_from_a_dual-cohort_retrospective_study_docx/34039839</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
